Aurasma Enhances Search With Images and Videos. ClimateGate 101: Berkeley professor explains the real scandal | IHateTheMedia.com. Technology. View.exacttarget. March 31, 2011, 05:04 AM EST Amgen to Appeal EMA's Negative Opinion on Vectibix Combination with Chemotherapy Firm claims clinical trials demonstrate that combination boosts progression-free survival in wild-type KRAS mCRC.
March 31, 2011, 08:51 AM EST RXi to Take Over Apthera for Late-Stage Breast Cancer Drug Phase III development of immunotherapeutic is projected to start by mid-2012. March 30, 2011, 07:10 AM EST Valeant Takes Unsolicited $5.7B Cash Offer for Cephalon to Shareholders Cephalon's recent acquisitions are undermining Valeant's $73 per share takeover bid, latter's CEO claims. March 30, 2011, 08:40 AM EST Amgen and Takeda's NSCLC Drug Fails in Phase III Study Firms will analyze trial data before deciding on future development prospects for motesanib. March 30, 2011, 09:14 AM EST Scientists Find New Mechanism of Glioma Invasion Team discovered that cells use bradykinin to metastasize, and an approved angioedema drug could block this process.
Cancer Marker Pursuit Heats Up.